The Indian glaucoma and cataract surgery devices market was valued at $164 million in 2016, and is expected to reach $321 million by 2023, registering a CAGR of 10.1% from 2017 to 2023. Glaucoma is a disease that causes vision loss owing to optic nerve damage. Cataract is the formation of dense, cloudy area that could affect the vision. The devices and instruments such as phacoemulsification systems, intraocular lenses, implants and stents, and glaucoma drainage aid in glaucoma and cataract surgical procedure to treat both the conditions efficiently.
Increase in prevalence of cataract disease as well as technological advancements in ophthalmic devices drives the market growth. Furthermore, increase in incidence of glaucoma and growth in geriatric population are projected to supplement the market growth. However, low awareness among people related to eye disorders and budget constrains caused by the high cost of these surgical devices hamper the market growth. Moreover, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma offer profitable opportunities for market expansion.
The Indian glaucoma and cataract surgery devices market is segmented into product, surgery type, and end user. Based on product, the market is bifurcated into glaucoma and cataract surgery devices. The glaucoma surgery devices market is further divided into glaucoma drainage device, glaucoma laser device, and implant & stent. The cataract surgery device is further classified into intraocular lens (IOL), ophthalmic viscoelastic device (OVD), and phacoemulsification equipment. Based on the surgery type, glaucoma surgery is bifurcated into conventional glaucoma surgery and minimally invasive glaucoma surgery; whereas, cataract surgery is further classified into phacoemulsification, extracapsular cataract extraction (ECCE) surgery, femtosecond laser surgery, and others. The end users are classified into hospital, ophthalmology clinic, and outpatient surgical center. Based on zones, the market is classified into north zone, east zone, west zone, south zone, central zone, and north-east zone.
KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on zone assists in understanding the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
Glaucoma Surgery Device
Implant & Stent
Glaucoma Drainage
Glaucoma Laser Device
Cataract Surgery Device
Intraocular Lens
Ophthalmic Viscoelastic Device
Phacoemulsification System
By Surgery Type
Glaucoma Surgery
Conventional Glaucoma Surgery
Minimally Invasive Glaucoma Surgery
Cataract Surgery
Phacoemulsification
Extracapsular Cataract Extraction (ECCE) Surgery
Femtosecond Laser Surgery
Others
By End Users
Hospital
Ophthalmology Clinic
Outpatient Surgery Center
By Zone
North Zone
East Zone
West Zone
South Zone
Central Zone
North-East Zone
KEY PLAYERS PROFILED
Alcon, Inc. (Novartis AG)
New World Medical, Inc.
Johnson & Johnson
Bausch & Lomb, Inc. (Valeant Pharmaceuticals International, Inc.)
Topcon Corporation
Lumenis Ltd.
Allergan plc.
Carl Zeiss Meditec AG
Essilor International S.A.
HAAG-Streit Holding AG
Nidek Co., Ltd.
Ziemer Ophthalmic Systems AG
Ellex Medical Lasers Ltd.
